rs148291843
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001128225.3(SLC39A13):āc.439C>Gā(p.Gln147Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00265 in 1,614,098 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001128225.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00206 AC: 313AN: 152242Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.00170 AC: 425AN: 250280Hom.: 1 AF XY: 0.00179 AC XY: 243AN XY: 135486
GnomAD4 exome AF: 0.00271 AC: 3959AN: 1461738Hom.: 8 Cov.: 32 AF XY: 0.00267 AC XY: 1943AN XY: 727168
GnomAD4 genome AF: 0.00205 AC: 313AN: 152360Hom.: 3 Cov.: 33 AF XY: 0.00203 AC XY: 151AN XY: 74510
ClinVar
Submissions by phenotype
not provided Benign:4
SLC39A13: BP4, BS2 -
- -
- -
- -
Ehlers-Danlos syndrome, spondylocheirodysplastic type Benign:2
SLC39A13 NM_152264.4 exon 4 p.Gln147Glu (c.439C>G): This variant has not been reported in the literature but is present in 0.3% (203/68032) of European alleles, including 3 homozygotes, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-47412369-C-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as likely benign (Variation ID: 287155). Evolutionary conservation for this variant is unclear. Computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. -
- -
Inborn genetic diseases Uncertain:1
The c.439C>G (p.Q147E) alteration is located in exon 4 (coding exon 3) of the SLC39A13 gene. This alteration results from a C to G substitution at nucleotide position 439, causing the glutamine (Q) at amino acid position 147 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
- -
SLC39A13-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Ehlers-Danlos syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at